β-1,4-Galactosyltransferase III enhances invasive phenotypes via β1-integrin and predicts poor prognosis in neuroblastoma

Clinical Cancer Research

Volumn 19, Issue 7, 2013, Pages 1705-1716

  Chang, Hsiu Hao ^a   Chen, Chia Hua ^b   Chou, Chih Hsing ^b   Liao, Yung Feng ^c   Huang, Miao Juei ^b,e   Chen, Ya Hsin ^b,e   Wang, Wei Jen ^b,e   Huang, John ^a   Hung, Ji Shiang ^a   Ho, Wan Ling ^d,f   Jeng, Yung Ming ^a   Che, Mei Ieng ^b   Lee, Hsinyu ^a,e   Lu, Meng Yao ^a   Yang, Yung Li ^a   Jou, Shiann Tarng ^a   Lin, Dong Tsamn ^a   Lin, Kai Hsin ^a   Hsu, Wen Ming ^a,e   Huang, Min Chuan ^b,e  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^c INSTITUTE OF CELLULAR AND ORGANISMIC BIOLOGY   (Taiwan)

^d SHIN KONG WU HO SU MEMORIAL HOSPITAL   (Taiwan)

^e NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^f FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

BETA 1,4 GALACTOSYLTRANSFERASE III; BETA1 INTEGRIN; FOCAL ADHESION KINASE; GALACTOSYLTRANSFERASE; UNCLASSIFIED DRUG;

ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER GROWTH; CANCER PROGNOSIS; CANCER STAGING; CANCER SURVIVAL; CELL MIGRATION; CHILD; CLINICAL FEATURE; CONTROLLED STUDY; DNA SEQUENCE; ENZYME ACTIVITY; ENZYME PHOSPHORYLATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOLECULAR PATHOLOGY; MOUSE; NEUROBLASTOMA; NONHUMAN; NUCLEOTIDE SEQUENCE; PHENOTYPE; PREDICTION; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN TARGETING; SURVIVAL RATE; TUMOR INVASION; UPREGULATION;

ANTIGENS, CD29; CELL LINE, TUMOR; CELL MOVEMENT; CHILD, PRESCHOOL; FEMALE; GALACTOSYLTRANSFERASES; GENE EXPRESSION; GLYCOSYLATION; HUMANS; INFANT; INFANT, NEWBORN; MALE; NEOPLASM INVASIVENESS; NEOPLASM STAGING; NEUROBLASTOMA; PHENOTYPE; PROGNOSIS; PROTEOLYSIS; SIGNAL TRANSDUCTION;

EID: 84877091745     PISSN: 10780432     EISSN: 15573265     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-12-2367     Document Type: Article

References (31)

1. Kamijo T, Nakagawara A. Molecular and genetic bases of neuroblastoma. Int J Clin Oncol 2012;17:190-5.
2. Maris JM, Hogarty MD, Bagatell R, Cohn SL. Neuroblastoma. Lancet 2007;369:2106-20. (Pubitemid 46935947)
3. Westermann F, Schwab M. Genetic parameters of neuroblastomas. Cancer Lett 2002;184:127-47. (Pubitemid 34804499)
4. Brodeur GM. Neuroblastoma: biological insights into a clinical enigma. Nat Rev Cancer 2003;3:203-16. (Pubitemid 37328872)
5. Reis CA, Osorio H, Silva L, Gomes C, David L. Alterations in glycosylation as biomarkers for cancer detection. J Clin Pathol 2010;63:322-9.
6. Hakomori S. Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acad Sci U S A 2002;99:10231-3.
7. Ohyama C, Tsuboi S, Fukuda M. Dual roles of sialyl Lewis X oligosaccharides in tumor metastasis and rejection by natural killer cells. Embo J 1999;18:1516-25. (Pubitemid 29127065)
8. Fukuda M, Hiraoka N, Yeh JC. C-type lectins and sialyl Lewis X oligosaccharides. Versatile roles in cell-cell interaction. J Cell Biol 1999;147:467-70. (Pubitemid 29523454)
9. Lowe JB. Glycosylation, immunity, and autoimmunity. Cell 2001;104:809-12. (Pubitemid 32289273)
10. Guo S, Sato T, Shirane K, Furukawa K. Galactosylation of N-linked oligosaccharides by human beta-1,4-galactosyltransferases I, II, III, IV, V, and VI expressed in Sf-9 cells. Glycobiology 2001;11:813-20. (Pubitemid 32982662)
11. Sasaki N, Manya H, Okubo R, Kobayashi K, Ishida H, Toda T, et al. beta4GalT-II is a key regulator of glycosylation of the proteins involved in neuronal development. Biochem Biophys Res Commun 2005;333:131-7. (Pubitemid 40813455)
12. Almeida R, Amado M, David L, Levery SB, Holmes EH, Merkx G, et al. A family of human beta4-galactosyltransferases. Cloning and expression of two novel UDP-galactose:beta-n-acetylglucosamine beta1, 4-galactosyltransferases, beta4Gal-T2 and beta4Gal-T3. J Biol Chem 1997;272:31979-91. (Pubitemid 28011864)
13. Ujita M, Misra AK, McAuliffe J, Hindsgaul O, Fukuda M. Poly-N-acetyllactosamine extension in N-glycans and core 2- and core 4-branched O-glycans is differentially controlled by i-extension enzyme and different members of the beta 1,4-galactosyltransferase gene family. J Biol Chem 2000;275:15868-75. (Pubitemid 30366888)
14. Zhao Y, Sato Y, Isaji T, Fukuda T, Matsumoto A, Miyoshi E, et al. Branched N-glycans regulate the biological functions of integrins and cadherins. FEBS J 2008;275:1939-48. (Pubitemid 351569538)
15. GuJ, Zhao Y, Isaji T, Shibukawa Y, Ihara H, Takahashi M, et al. Beta1,4-N-acetylglucosaminyltransferase III down-regulates neurite outgrowth induced by costimulation of epidermal growth factor and integrins through the Ras/ERK signaling pathway in PC12 cells. Glycobiology 2004;14:177- 86.
16. Guo HB, Lee I, Kamar M, Akiyama SK, Pierce M. Aberrant Nglycosylation of beta1 integrin causes reduced alpha5beta1 integrin clustering and stimulates cell migration. Cancer Res 2002;62:6837-45. (Pubitemid 35424070)
17. Lee SH, Hatakeyama S, Yu SY, Bao X, Ohyama C, Khoo KH, et al. Core3 O-glycan synthase suppresses tumor formation and metastasis of prostate carcinoma PC3 and LNCaP cells through down-regulation of alpha2beta1 integrin complex. J Biol Chem 2009;284:17157-69.
18. Hsu WM, Che MI, Liao YF, Chang HH, Chen CH, Huang YM, et al. B4GALNT3 expression predicts a favorable prognosis and suppresses cell migration and invasion via beta(1) integrin signaling in neuroblastoma. Am J Pathol 179:1394- 404.
19. Isaji T, Kariya Y, Xu Q, Fukuda T, Taniguchi N, Gu J. Functional roles of the bisecting GlcNAc in integrin-mediated cell adhesion. Methods Enzymol 2010;480:445-59.
20. Bellis SL, Newman E, Friedman EA. Steps in integrin beta1-chain glycosylation mediated by TGFbeta1 signaling through Ras. J Cell Physiol 1999;181:33- 44.
21. Dennis JW, Pawling J, Cheung P, Partridge E, Demetriou M. UDP-N-acetylglucosamine: alpha-6-D-mannoside beta1,6 N- acetylglucosaminyltransferase V (Mgat5) deficient mice. Biochim Biophys Acta 2002;1573:414-22. (Pubitemid 35335452)
22. Prokopishyn NL, Puzon-McLaughlin W, Takada Y, Laferte S. Integrin alpha3beta1 expressed by human colon cancer cells is a major carrier of oncodevelopmental carbohydrate epitopes. J Cell Biochem 1999;72:189- 209.
23. Litynska A, Pochec E, Hoja-Lukowicz D, Kremser E, Laidler P, Amoresano A, et al. The structure of the oligosaccharides of alpha3beta1 integrin from human ureter epithelium (HCV29) cell line. Acta Biochim Pol 2002;49:491-500. (Pubitemid 135686795)
24. Meyer A, van Golen CM, Kim B, van Golen KL, Feldman EL. Integrin expression regulates neuroblastoma attachment and migration. Neoplasia 2004;6:332-42. (Pubitemid 38924848)
25. Janik ME, Litynska A, Vereecken P. Cell migration-the role of integrin glycosylation. Biochim Biophys Acta 2010;1800:545-55.
26. Palecek SP, Huttenlocher A, Horwitz AF, Lauffenburger DA. Physical and biochemical regulation of integrin release during rear detachment of migrating cells. J Cell Sci 1998;111(Pt 7):929-40. (Pubitemid 28196076)
27. Palecek SP, Horwitz AF, Lauffenburger DA. Kinetic model for integrin-mediated adhesion release during cell migration. Ann Biomed Eng 1999;27:219- 35.
28. Barkan D, Chambers AF. Beta1-integrin: a potential therapeutic target in the battle against cancer recurrence. Clin Cancer Res 2011;17:7219-23.
29. Bao X, Kobayashi M, Hatakeyama S, Angata K, Gullberg D, Nakayama J, et al. Tumor suppressor function of laminin-binding alpha-dystroglycan requires a distinct beta3-N-acetylglucosaminyltransferase. Proc Natl Acad Sci U S A 2009;106:12109-14.
30. Stupack DG, Puente XS, Boutsaboualoy S, Storgard CM, Cheresh DA. Apoptosis of adherent cells by recruitment of caspase-8 to unligated integrins. J Cell Biol 2001;155:459-70. (Pubitemid 34289336)
31. Stupack DG, Teitz T, Potter MD, Mikolon D, Houghton PJ, Kidd VJ, et al. Potentiation of neuroblastoma metastasis by loss of caspase-8. Nature 2006;439:95-9. (Pubitemid 43053635)